(Q34553049)

3 August 2017

Tonic dopaminergic stimulation impairs associative learning in healthy subjects (English)

1 reference

3 August 2017

1 reference

Stefan Knecht

6

0 references

author name string

Caterina Breitenstein

1

1 reference

3 August 2017

Catharina Korsukewitz

2

1 reference

3 August 2017

Agnes Flöel

3

1 reference

3 August 2017

Timo Kretzschmar

4

1 reference

3 August 2017

Kai Diederich

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

26 July 2006

1 reference

3 August 2017

Neuropsychopharmacology

1 reference

3 August 2017

31

1 reference

3 August 2017

11

1 reference

3 August 2017

2552-2564

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301167

3 August 2017

0 references

cites work

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

A synaptic model of memory: long-term potentiation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Hippocampus activity differentiates good from poor learners of a novel lexicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Development and validation of a language learning model for behavioral and functional-imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Cabergoline : a review of its use in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine, depression and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The investigation of functional brain lateralization by transcranial Doppler sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The uncertain nature of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Discrete coding of reward probability and uncertainty by dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Evidence that the delay-period activity of dopamine neurons corresponds to reward uncertainty rather than backpropagating TD errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic influences on formation of a motor memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic effects on encoding of a motor memory in chronic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

An open-label trial of bromocriptine in nonfluent aphasia: a qualitative analysis of word storage and retrieval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Bromocriptine treatment of nonfluent aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine receptors and brain function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Levodopa strengths and weaknesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine: a potential substrate for synaptic plasticity and memory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The molecular biology of memory storage: a dialogue between genes and synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Cognitive effects of the dopamine receptor agonist pergolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Effects of bromocriptine on human subjects depend on working memory capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Levodopa: faster and better word learning in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Mechanism of action of dopaminergic agents in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Present status and future possibilities of adjuvant pharmacotherapy for aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopaminergic modulation of cortical function in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Autoreceptor preference of dopamine D2 receptor agonists correlates with preferential coupling to cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine and the regulation of cognition and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The assessment and analysis of handedness: The Edinburgh inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine D-1 receptors in the parkinsonian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Distinguishing whether dopamine regulates liking, wanting, and/or learning about rewards

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Differential dopaminergic modulation of executive control in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

An open-label trial of bromocriptine in nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine neurons and their role in reward mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Getting formal with dopamine and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Mechanisms of neurotransmitter release by amphetamines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Adaptive coding of reward value by dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Dopamine responses comply with basic assumptions of formal learning theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Development and validation of brief measures of positive and negative affect: The PANAS scales

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

21 January 2018

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Mechanisms by which dopamine receptors may influence synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

D(1) receptors in prefrontal cells and circuits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

Bromocriptine treatment of nonfluent aphasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

Working memory and dopamine: clinical and experimental clues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

D1- versus D2-receptor modulation of visuospatial working memory in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

Pharmacokinetics of Levodopa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301167

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301167

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference